Supreme Court refuses Mylan's antitrust appeal; P.R. family claims Baxter tainted property;

@FiercePharma: Merck's Fosamax-suit score hits 3-1: Juries find for $MRK in all but one bellwether case. News | Follow @FiercePharma

> The U.S. Supreme Court refused to hear Mylan's appeal of a $77 million award to four insurers that said the company cornered the market on ingredients for anti-anxiety drugs. Report

> A Puerto Rican family has sued Baxter International, saying that a company warehouse contaminated their property with radioactive cobalt and other hazardous materials. Story

> Pozen issued a new revenue forecast after a district court upheld patents on its migraine drug Treximet. Story

> Dramatic increases in oral cancer since 1984 can be attributed to HPV infection, a new study found, with more than 70% of oral cancers now linked with the virus, compared with 16% in the 1980s. Item

> Increasing numbers of Medicare beneficiaries game the system to fill prescriptions for the painkillers and other narcotics they abuse. Report

> Florida officials offered an incentive package to Pharmacy South, a drugmaker that may establish a new manufacturing plant in the state. Report

> The most popular contraceptive for women in parts of Africa, a hormone shot, appears to double the risk of HIV infection. More

Biotech News

@FierceBiotech: AZ's MedImmune signs agreement with Pfizer for tremelimumab, a CTLA-4 monoclonal antibody that's a potential cancer treatment. Story | Follow @FierceBiotech

@ JohnCFierce: Mymetics "reclaims" flu vax from Solvay. $MYMX stock plunges 25% on the score, which means a loss of one cent. Release | Follow @JohnCFierce

@RyanMFierce: I caught up with four cool life sciences tech outfits with ties to the Boston area for my companies-to-watch report. Story | Follow @RyanMFierce

@MaureenFierce: Influenza pandemic prompts EMA vaccine quality rethink. Item | Follow @MaureenFierce

> Abbott venture arm takes lead on $20M Creabilis round. More

> Merck KGaA bolsters MS pipeline in $20M pact with Ono. News

Manufacturing News

> DHL, pharma group assess India's hobbled logistics. Story

> Hill Dermaceuticals enters consent decree with FDA. News

> Novo to enhance insulin in manufacturing/marketing strategy. Report

> Boehringer to launch biosimilars unit. Item

> FDA: Product quality issues fuel rise in drug shortages. Story

> Lonza readies as pharma sector boosts Singapore production. Article

Biotech Research News

> Pioneering Scripps scientist devotes a lifetime to addiction vaccines. Piece

> New mouse models open a window on autism research. Report

> Controversial XMRV study author fired from research post. More

> NIH kicks off $110M Knockout Mouse Project. Article

> Targeted treatment clears glioblastoma tumors in drug-resistant models. Story

> GSK's epigenetics team tests promising leukemia drug in mice. Item

And Finally... Lobbyists send patients and their stories to "super-committee" members considering Medicaid cuts. Report

Suggested Articles

After a major label expansion in December, Amarin's Vascepa is preparing a major boom in sales with its marketing team nearly scaled up.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

Data on Roche's Polivy aren't yet enough to win support from England's cost watchdogs, who rejected the medicine based on long-term…